Effectiveness of mrna boosters after homologous primary series with bnt162b2 or chadox1 against symptomatic infection and severe covid-19 in brazil and scotland: a test-negative design case-control study

HIGHLIGHTS

• who: Thiago Cerqueira-Silva and collaborators from the and, Instituto Goncu0327alo Moniz, Fiocruz, Brazil, Universidade have published the Article: Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study, in the Journal: (JOURNAL) of April/23,/2022
• what: The authors aimed to assess the extent and duration of protection against Omicron-associated symptomatic infection and severe outcomes (i.e., COVID-19 hospitalization and death) after an mRNA booster dose in individuals of different age groups . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.